Adapting Radiation Therapy Treatments for Patients with Breast Cancer During the COVID-19 Pandemic: Hypo-Fractionation and Accelerated Partial Breast Irradiation to Address World Health Organization Recommendations
Authors:
Open Access
- 1 July 2020
- journal article
- letter
- Published by Elsevier in Advances in Radiation Oncology
- Vol. 5 (4) , 575-576
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Letter from SwitzerlandInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2020
- Hypofractionated radiation treatment for breast cancer: The time is nowThe Breast Journal, 2020
- Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trialThe Lancet, 2019
- External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trialThe Lancet, 2019
- One-Year Cosmesis and Fibrosis From ACCEL: Accelerated Partial Breast Irradiation (APBI) Using 27 Gy in 5 Daily FractionsPractical Radiation Oncology, 2019
- Five-field IMRT class solutions and dosimetric planning guidelines for implementing accelerated partial breast irradiationPractical Radiation Oncology, 2018
- Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guidelinePractical Radiation Oncology, 2018
- Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward TrialRadiotherapy and Oncology, 2016
- Long-Term Results of Hypofractionated Radiation Therapy for Breast CancerNew England Journal of Medicine, 2010